×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:

1800 Total Publications

Discriminative Feature Selection for Uncertain Graph Classification.
Kong X, Yu P, Wang X, Ragin A.
2013; Journal arXiv Prepr; vol. 2013; pp. 82-93; AWUVFUjTMOwVf_qbJr8Q
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease.
Lambert, J. C., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., … Amouyel, P.
2013; Journal Nature Genetics; vol. 45; no. 12; pp. 1452-8; AWUVGYvTMOwVf_qbJr8y doi:10.1038/ng.2802
Visual ratings of atrophy in MCI: Prediction of conversion and relationship with CSF biomarkers.
Lehmann, M., Koedam, E. L., Barnes, J., Bartlett, J. W., Barkhof, F., Wattjes, M. P., … Fox, N. C.
2013; Journal Neurobiology of Aging; vol. 34; no. 1; pp. 73-82; AWUVGYvTMOwVf_qbJr80 doi:10.1016/j.neurobiolaging.2012.03.010
Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer’s disease.
Dukart, J., Mueller, K., Villringer, A., Kherif, F., Draganski, B., Frackowiak, R., & Schroeter, M. L.
2013; Journal Neuroimage: Clinical; vol. 3; pp. 84-94; AWUVGYvTMOwVf_qbJr82 doi:10.1016/j.nicl.2013.07.005
Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration.
Rahul S Desikan, Wesley K Thompson, Dominic Holland, Christopher P Hess, James B Brewer, Henrik Zetterberg, Kaj Blennow, Ole A Andreassen, Linda K McEvoy, Bradley T Hyman, Anders M Dale, and for the Alzheimer’s Disease Neuroimaging Initiative.
2013; Journal Molecular Neurodegeneration; vol. 8; no. 39; AWUVAA3tMOwVf_qbJr70 doi:10.1186/1750-1326-8-39
A direct morphometric comparison of five labeling protocols for multi-atlas driven automatic segmentation of the hippocampus in Alzheimer’s disease
Nestor, S. M., Gibson, E., Gao, F. Q., Kiss, A., & Black, S. E.
2013; Journal Neuroimage; vol. 66; pp. 50-70; AWUVAA3tMOwVf_qbJr76 doi:10.1016/j.neuroimage.2012.10.081
Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people.
Wirth, M., Villeneuve, S., Haase, C. M., Madison, C. M., Oh, H., Landau, S. M., … Jagust, W. J.
2013; Journal JAMA Neurology; vol. 70; no. 12; pp. 1512-9; AWUVIqi8dzjauPDbjhrC doi:10.1001/jamaneurol.2013.4013
Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.
Leung, K. K., Bartlett, J. W., Barnes, J., Manning, E. N., Ourselin, S., & Fox, N. C.
2013; Journal Neurology; vol. 80; no. 7; pp. 648-54; AWUVIqi8dzjauPDbjhrM doi:10.1212/WNL.0b013e318281ccd3
Structural interactions within the default mode network identified by Bayesian network analysis in Alzheimer’s disease.
Wang, Y., Chen, K., Yao, L., Jin, Z., & Guo, X.
2013; Journal PloS One; vol. 8; no. 8; pp. e74070; AWUVIqi8dzjauPDbjhrQ doi:10.1371/journal.pone.0074070
Disease progression model in subjects with mild cognitive impairment from the Alzheimer’s disease neuroimaging initiative: CSF biomarkers predict population subtypes.
Samtani, M. N., Raghavan, N., Shi, Y., Novak, G., Farnum, M., Lobanov, V., … Narayan, V. a.
2013; Journal British Journal of Clinical Pharmacology; vol. 75; no. 1; pp. 146-161; AWUU_d3HdzjauPDbjhqf doi:10.1111/j.1365-2125.2012.04308.x